<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">SS</journal-id><journal-title-group><journal-title>Surgical Science</journal-title></journal-title-group><issn pub-type="epub">2157-9407</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ss.2022.133013</article-id><article-id pub-id-type="publisher-id">SS-115777</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  The Epidemiological Profil of Digestive Cancers in Secondary and Tertiary Health Care Facilities in Cameroon
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yannick</surname><given-names>Ekani Boukar Mahamat</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Georges</surname><given-names>Bwelle</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cyrille</surname><given-names>Chopkeng</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Freddy</surname><given-names>Bombah</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fabrice</surname><given-names>Tietche Tim</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guy</surname><given-names>Aristide Bang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Eric</surname><given-names>Patrick Savom</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Divine</surname><given-names>Mokake</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alain</surname><given-names>Chichom</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Arthur</surname><given-names>Essomba</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marcellin</surname><given-names>Ngowe</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maurice</surname><given-names>Aurelien Sosso</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Department of Surgery, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Department of Surgery, Faculty of Health Sciences, University of Buea, Buea, Cameroon</addr-line></aff><aff id="aff3"><addr-line>Digestive Surgery Unit, Central Hospital of Yaounde, Yaounde, Cameroon</addr-line></aff><aff id="aff2"><addr-line>Department of Surgery, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon</addr-line></aff><pub-date pub-type="epub"><day>07</day><month>03</month><year>2022</year></pub-date><volume>13</volume><issue>03</issue><fpage>98</fpage><lpage>104</lpage><history><date date-type="received"><day>24,</day>	<month>January</month>	<year>2022</year></date><date date-type="rev-recd"><day>7,</day>	<month>March</month>	<year>2022</year>	</date><date date-type="accepted"><day>10,</day>	<month>March</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Background:</b>
  
  <b> </b>
  Cancers have been a major public health problem in developing countries in recent years. The aim of this study was to determine the epidemiological profile of digestive cancers in secondary and tertiary health care facilities in Cameroon. <b></b>
  <b><b>Methodology:</b></b>
  <b> </b>
  This was a cross sectional and descriptive study conducted over a period of 12 months in 14 health structures over the national territory. Included in our study were patients aged 15 and above with a histologically proven digestive cancer, patients with a clinical, biological and morphologic evidence of a digestive cancer. Socio-demographic (age, gender, region of origin, profession), clinical (symptoms on diagnosis, personal and family past history, consumption habits, tumour location) and paraclinical data were recorded on a pretested questionnaire. Data was analysed using SPSS version 20.0. Quantitative data was expressed as means with their corresponding standard deviations. Chi square was used for correlation between variables. A P value &lt;
   
  0.05 was considered statistically significant. <b></b><b><b>Results:</b></b> Five hundred and eighty-two cases of digestive cancers were recorded out of 37
  ,
  780 consultations/admissions during the study period giving a prevalence of 1.5% with a male predominance (58.1%). The mean age was 53.11 &#177; 17.26 years (15
   
  -
   
  99) with 33.8% of them below 45 years of age. Tumours were predominantly localized in the liver (43.5%) and colon (24.9%). Adenocarcinoma was the most common histological type in 44.5% of all cases. Alcohol consumption was found to be associated with colorectal cancer (p =
   
  0.028) while tobacco consumption was found to be significantly associated with oesophageal cancer (p
   
  ≤
   
  0.001) and gastric cancer (p
   
  =
   
  0.0047). <b></b><b><b>Conclusion:</b></b> A third of patients with digestive cancers were aged less than 45 years suggesting an early onset of these cancers in our setting. Relatively low prevalence with the liver being the most common site of localisation in our setting.
 
</p></abstract><kwd-group><kwd>Digestive Cancer</kwd><kwd> Secondary and Tertiary Health Care Facilities</kwd><kwd> Cameroon</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cancer is one of the major causes of death in adults. One out of 10 deaths worldwide is associated with cancer related causes [<xref ref-type="bibr" rid="scirp.115777-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.115777-ref2">2</xref>]. Cancers with the highest mortality rate worldwide include those of the lungs, stomach and liver [<xref ref-type="bibr" rid="scirp.115777-ref3">3</xref>]. Despite the use of diagnostic endoscopy to identify digestive cancers in Cameroon, most of these patients present late with advanced disease. More so, we have very few clinical pathology laboratories and clinical pathologists in Cameroon and data on the epidemiologic and clinical profile of digestive cancers is rare. We therefore sought to determine the epidemiological and clinical profile of patients with digestive cancers.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This was a cross sectional and descriptive study conducted over a period of 12 months in 14 health structures over the national territory (Yaound&#233; central hospital, university teaching hospital Yaound&#233;, Yaound&#233; general hospital, Essos hospital centre, Douala general Hospital, Laquintinie hospital, Buea regional hospital, Bafoussam regional hospital, Bertoua regional hospital, Garoua regional hospital, Ngaoundere regional hospital, Ebolowa regional hospital, Maroua regional hospital, and Mbingo Baptist hospital).</p><p>Digestive cancers refer to all malignant tumours that develop with the digestive tract as their starting point. During the study period we searched the hospital consultation registers for all patients with a diagnosis of digestive cancer. Then we collected all the files of these patients. The files that included pathology reports were selected. Included in our study were patients aged 15 and above with a histologically proven digestive cancer, patients with a clinical, biological and morphologic evidence of a digestive cancer.</p><p>A pre-arranged questionnaire was then completed. It included the Socio-de- mographic (age, gender, region of origin, profession), clinical (symptoms on diagnosis, personal and family past history, consumption habits, tumour location) and paraclinical data. Data was analysed using SPSS version 20.0. Quantitative data was expressed as means with their corresponding standard deviations. Chi square was used for correlation between variables. A P value &lt; 0.05 was considered statistically significant.</p><p>Administrative authorisation was obtained from the various health facility review boards while ethical clearance was procured from the University of Douala institutional review board.</p></sec><sec id="s3"><title>3. Results</title><p>Five hundred and eighty-two cases of digestive cancers were recorded out of 37,780 consultations/admissions during the study period giving a prevalence of 1.5% with a male predominance (58.1%). The mean age was 53.11 &#177; 17.26 years (15 - 99) with 33.7% of them below 45 years of age with 55 - 65 years being the most represented age group (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Tumours were predominantly localized in the liver (43.5%) and colon (24.9%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Asthenia (96.6%) and weight loss (95.9%), were the most common symptoms on diagnosis (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>The median duration between onset of symptoms and patient consultation was 5.99 months (1 - 60 months). Adenocarcinoma was the most common histological type found in tumours of the lower gastrointestinal tract including the liver and bile ducts. <xref ref-type="table" rid="table3">Table 3</xref> shows the cancer histology according to their location.</p><p>HIV serology was positive in 11% of patients, hepatitis B in 35.5% and hepatitis C in 35% of patients, 78.9% of patients were alcohol consumers, 15.5% were permanent smokers and 76.1% were physically inactive, 66.2% of patients had regular consumption of smoked foods. 94.7% of patients had regular consumption of salty foods. Alcohol consumption was found to be associated with colorectal cancer (p = 0.028) while tobacco consumption was found to be significantly associated with oesophageal cancer (p ≤0.001) and gastric cancer (p = 0.0047) (<xref ref-type="table" rid="table4">Table 4</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Repartition of patients according to age</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Age</th><th align="center" valign="middle" >Effective n = 582</th><th align="center" valign="middle" >Percentage %</th></tr></thead><tr><td align="center" valign="middle" >[15 - 25[</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >5.6</td></tr><tr><td align="center" valign="middle" >[25 - 35[</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >11.3</td></tr><tr><td align="center" valign="middle" >[35 - 45[</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >16.8</td></tr><tr><td align="center" valign="middle" >[45 - 55[</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >14.6</td></tr><tr><td align="center" valign="middle" >[55 - 65[</td><td align="center" valign="middle" >133</td><td align="center" valign="middle" >22.8</td></tr><tr><td align="center" valign="middle" >[65 - 75[</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >18.5</td></tr><tr><td align="center" valign="middle" >≥75</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >10.1</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Clinical features of patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Physical signs</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >Percentage %</th></tr></thead><tr><td align="center" valign="middle" >Asthenia</td><td align="center" valign="middle" >562</td><td align="center" valign="middle" >96.6</td></tr><tr><td align="center" valign="middle" >Weight loss</td><td align="center" valign="middle" >558</td><td align="center" valign="middle" >95.9</td></tr><tr><td align="center" valign="middle" >Abdominal pain</td><td align="center" valign="middle" >496</td><td align="center" valign="middle" >85.2</td></tr><tr><td align="center" valign="middle" >Anorexia</td><td align="center" valign="middle" >342</td><td align="center" valign="middle" >58.8</td></tr><tr><td align="center" valign="middle" >Hepatomegaly</td><td align="center" valign="middle" >261</td><td align="center" valign="middle" >44.8</td></tr><tr><td align="center" valign="middle" >Jaundice</td><td align="center" valign="middle" >225</td><td align="center" valign="middle" >38.7</td></tr><tr><td align="center" valign="middle" >Change in bowel habits</td><td align="center" valign="middle" >224</td><td align="center" valign="middle" >38.5</td></tr><tr><td align="center" valign="middle" >Anemia</td><td align="center" valign="middle" >149</td><td align="center" valign="middle" >25.6</td></tr><tr><td align="center" valign="middle" >Ascites</td><td align="center" valign="middle" >131</td><td align="center" valign="middle" >22.5</td></tr><tr><td align="center" valign="middle" >Rectorrhagia</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >15.3</td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >10.3</td></tr><tr><td align="center" valign="middle" >splenomegaly</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >8.4</td></tr><tr><td align="center" valign="middle" >Abdominal mass</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >6.87</td></tr><tr><td align="center" valign="middle" >Superficial adenopathies</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >6.35</td></tr><tr><td align="center" valign="middle" >Dysphagia</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >3.3</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Cancer histology according to location</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Location</th><th align="center" valign="middle" >Histology</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Esophagus n = 13</td><td align="center" valign="middle" >Epidermoid carcinoma</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >53.8</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Adenocarcinoma</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >30.7</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Atypical</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >15.3</td></tr><tr><td align="center" valign="middle" >Stomach n = 83</td><td align="center" valign="middle" >Adenocarcinoma</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >81.9</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Carcinoma</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >8.4</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Leiomyosarcoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.2</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Lymphoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.2</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Atypical</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.2</td></tr><tr><td align="center" valign="middle" >Liver n = 118</td><td align="center" valign="middle" >Hepatocellular carcinoma</td><td align="center" valign="middle" >118</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Colorectal n = 130</td><td align="center" valign="middle" >Adenocarcinoma</td><td align="center" valign="middle" >117</td><td align="center" valign="middle" >90</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Carcinoma</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >Pancreas n = 12</td><td align="center" valign="middle" >Adenocarcinoma</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Gallbladder and biliary tract n = 1</td><td align="center" valign="middle" >Cholangiosarcoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Small intestine n = 4</td><td align="center" valign="middle" >Adenocarcinoma</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >75</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Lymphoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Anus n = 16</td><td align="center" valign="middle" >Adenocarcinoma</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >56.2</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Epidermoid carcinoma</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >31.2</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Angiosarcoma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >6.2</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Atypical</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >6.2</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Factors associated with cancer</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Œsophagus N/Total p value</th><th align="center" valign="middle" >Stomach N/Total p value</th><th align="center" valign="middle" >Pancreas N/Total p value</th><th align="center" valign="middle" >Small intestine N/Total p value</th><th align="center" valign="middle" >Colorectal N/Total p value</th><th align="center" valign="middle" >Anus N/Total p value</th><th align="center" valign="middle" >Liver N/Total p value</th><th align="center" valign="middle" >Gallblader and biliary tract N/Total p value</th></tr></thead><tr><td align="center" valign="middle" >Up to 55 years</td><td align="center" valign="middle" >5/16 0.03</td><td align="center" valign="middle" >24/89 0.59</td><td align="center" valign="middle" >17/57 0.05</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >40/145 0.05</td><td align="center" valign="middle" >1/16 0.18</td><td align="center" valign="middle" >46/337 0.08</td><td align="center" valign="middle" >/</td></tr><tr><td align="center" valign="middle" >Alcohol</td><td align="center" valign="middle" >15/16 0.13</td><td align="center" valign="middle" >76/89 0.10</td><td align="center" valign="middle" >45/57 0.98</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >105/145 0.02</td><td align="center" valign="middle" >13/16 0.81</td><td align="center" valign="middle" >199/253 0.91</td><td align="center" valign="middle" >/</td></tr><tr><td align="center" valign="middle" >Tobacco</td><td align="center" valign="middle" >9/16 &lt;0.001</td><td align="center" valign="middle" >20/89 0.004</td><td align="center" valign="middle" >7/57 0.48</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >19/145 0.36</td><td align="center" valign="middle" >3/16 0.71</td><td align="center" valign="middle" >32/253 0.09</td><td align="center" valign="middle" >/</td></tr><tr><td align="center" valign="middle" >Sedentary lifestyle</td><td align="center" valign="middle" >12/16 0.91</td><td align="center" valign="middle" >73/83 0.15</td><td align="center" valign="middle" >46/57 0.39</td><td align="center" valign="middle" >/</td><td align="center" valign="middle" >102/145 0.06</td><td align="center" valign="middle" >13/16 0.62</td><td align="center" valign="middle" >192/253 0.91</td><td align="center" valign="middle" >/</td></tr><tr><td align="center" valign="middle" >Ag Hbs</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >119/207 &lt;0.05</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Ac anti HVC</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >118/204 &lt;0.05</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>Oesophageal cancer was more common in patients between 55 - 64 years of age (p = 0.034).</p></sec><sec id="s4"><title>4. Discussion</title><p>The mean age was 53.11 &#177; 17.26 years (15 - 99) with 33.8% of them below 45 years of age with a male predominance (58.1%) thus a relatively young population. Several authors in Africa [<xref ref-type="bibr" rid="scirp.115777-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.115777-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.115777-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.115777-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.115777-ref8">8</xref>] have reported similar young ages in the onset of digestive cancers whereas Western studies show a late onset in digestive cancers between 60 - 70 years of age [<xref ref-type="bibr" rid="scirp.115777-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.115777-ref10">10</xref>]. This could be partially explained by the presence of undiagnosed hereditary forms in our setting and thus suggesting oncogenetic screening in our setting.</p><p>Liver cancer was the most common digestive cancer (43.5%) with 47.1% of these patients having a positive HbsAg and 46.6% with positive HCV antibodies. Early studies in Cameroon [<xref ref-type="bibr" rid="scirp.115777-ref11">11</xref>] reported the liver as the most common site of digestive cancers. This could be explained by the presence of risk factors such as high viral hepatitis (B and C) prevalence in our setting which rather has a predominant vertical and horizontal transmission in our setting responsible for the early onset of this cancer. This finding however contrasts with other studies worldwide [<xref ref-type="bibr" rid="scirp.115777-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.115777-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.115777-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.115777-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.115777-ref14">14</xref>] which have colorectal cancer as the most frequent digestive cancer worldwide.</p><p>Asthenia, weight loss and abdominal pains were the most common symptoms. These symptoms are however non-specific and won’t prompt initial high index of suspicion of digestive cancers. As such most patients usually consult severally, use traditional potions before the diagnosis is made and thus present lately with advanced disease. This late presentation for care has been reported by certain authors [<xref ref-type="bibr" rid="scirp.115777-ref6">6</xref>].</p><p>The prevalence of digestive cancers in this series was found to be 1.5% which is relatively low. Several authors in Africa reported prevalence ranging between 12.7% - 37% [<xref ref-type="bibr" rid="scirp.115777-ref5">5</xref>]. This difference could be explained by the fact that these studies were done over a longer period and included even many more patients. Though digestive endoscopy has increased cancer detection in our setting, it is readily not available and we equally have few trained clinical pathologists. All of these could explain low detection rate.</p><p>Seventy-eight point nine of patients were alcohol consumers, 15.5% were permanent smokers and 76.1% were physically inactive, 66.2% of patients had regular consumption of smoked foods, 94.7% of patients had regular consumption of salty foods. All of these factors have been reported to be associated with various forms of cancers. As such alcohol consumption was found to be associated with colorectal cancer (p = 0.028) while tobacco consumption was found to be significantly associated with oesophageal cancer (p ≤ 0.001) and gastric cancer (p = 0.0047). Oesophageal cancer was more common in patients between 55 - 64 years of age (p = 0.034).</p><p>The main limitation of our work was the relatively short study period. On the other hand, its multicentric nature allowed us to have a representative sample from all of Cameroon, as recruitment was done in all regions</p></sec><sec id="s5"><title>5. Conclusion</title><p>Digestive cancers are a public health problem in our country, because of their frequency, which seems to have doubled over the last two decades, but also because of their severity. One of the difficulties remains the availability of clinical pathology laboratories in the district hospitals delaying diagnosis and management. Long-time considered to be the prerogative of the male sex that we also found predominant, they have increasingly reached women. Despite the fact that the mean age of onset of digestive cancers was 53.11 years, patients under 45 years of age represented about one-third of our series. It thus appears that overall age of cancer onset is early in our setting, as compared to Western series. The main risk factors were the consumption of alcohol, tobacco. The liver remains the most affected digestive organ a quarter of a century later, due to a high frequency of viral hepatitis in our country. The routine vaccination of new-borns is currently raising hopes for a reduction in the prevalence of these cancers if this strategy is sustained and expanded.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Mahamat, Y.E.B., Bwelle, G., Chopkeng, C., Bombah, F., Tim, F.T., Bang, G.A., Savom, E.P., Mokake, D., Chichom, A., Essomba, A., Ngowe, M. and Sosso, M.A. (2022) The Epidemiological Profil of Digestive Cancers in Secondary and Tertiary Health Care Facilities in Cameroon. Surgical Science, 13, 98-104. https://doi.org/10.4236/ss.2022.133013</p></sec></body><back><ref-list><title>References</title><ref id="scirp.115777-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">OMS (2013) Centre International de Recherche sur le Cancer. Derni&amp;#232res statistiques mondiales sur le cancer. Communiqu&amp;#233 de presse, 1-3.</mixed-citation></ref><ref id="scirp.115777-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">OMS (2014) Principales causes de mortalit&amp;#233 dans le monde. Aide-m&amp;#233moire, 1-5.</mixed-citation></ref><ref id="scirp.115777-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ndahindwa, V., Ngendahayo, L. and Vyankandondera, J. (2012) Aspects &amp;#233pid&amp;#233miologiques et anatomopathologiques des cancers dans les centres hospitaliers universitaires (CHU) du Rwanda. Revue m&amp;#233Dicale Rwandaise, 69, 40-49.</mixed-citation></ref><ref id="scirp.115777-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Guemne, T.A., Ndjitoyap Ndam, E.C., Mbakop, A., Michel, G., Njoya, O., Abondo, A. and Ngu Anomah, V. (1990) Les cancers digestifs au Cameroun. R&amp;#233sultats pr&amp;#233liminaires. M&amp;#233decine et Chirurgie Digestives, 19, 301.</mixed-citation></ref><ref id="scirp.115777-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Ayite, A.E., Dosseh, E., Senah, K., Etey, K., Napo-Koura, G. and James, K. (2001) Epid&amp;#233miologie descriptive des cancers digestifs au Togo. Journal Africain de Chirurgie Digestive, 1, 10-16.</mixed-citation></ref><ref id="scirp.115777-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Diarra Cheick, A. (2009) Epid&amp;#233miologie des cancers digestifs en milieu hospitalier. Th&amp;#232se De Doctorat En M&amp;#233decine, Universit&amp;#233 De Bamako, 113.</mixed-citation></ref><ref id="scirp.115777-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Mamoudou, G., Hinde, H., Abdelmadjid, S. and Ali, Q. (2014) Les cancers digestifs au Niger. Fr&amp;#233quence relative sur une &amp;#233tude r&amp;#233trospective de 1992 A 2009. European Scientific Journal, 10, 339-349.</mixed-citation></ref><ref id="scirp.115777-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Segol, P.h., Verwaerde, J.c. and Fournir, J.l. (1994) Notions fondamentales et diagnostiques. Encyclop&amp;#233die M&amp;#233dico-Chirurgicale, 10, 9-27.</mixed-citation></ref><ref id="scirp.115777-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Chbani, L., Hafid, I., Berraho, M., Mesbahi, O., Nejjari, C. and et Amarti, A. (2013) Aspects &amp;#233pid&amp;#233miologiques et anatomopathologiques des cancers dans la r&amp;#233gion de F&amp;#232s-Boulemane (Maroc). Eastern Mediterranean Health Journal, 19, 263. https://doi.org/10.26719/2013.19.3.263</mixed-citation></ref><ref id="scirp.115777-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Peghini, M., Rajaonarison, P., Pecadesse, J.L., Razafidramboa, H., Richard, J. and Morin, D. (1997) Epid&amp;#233miologie des cancers du tube digestif &amp;#224 Madagascar; Apport de 14 000 endoscopies effectu&amp;#233es au Centre Hospitalier de Soanviandriana &amp;#224 Antananarivo. M&amp;#233decine d’Afrique Noire, 44, 518-521.</mixed-citation></ref><ref id="scirp.115777-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takongmo</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> Essame-Oyono</surname><given-names> J.l.</given-names></name>,<name name-style="western"><surname> Binam</surname><given-names> F.</given-names></name>,<name name-style="western"><surname> Sadou Malonga</surname><given-names> E.E. </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>Les cancers colorectaux du sujet de moins de 40 Ans &amp;#224 Yaound&amp;#233: Des particularit&amp;#233s anatomocliniques</article-title><source> M&amp;#233decine d’Afrique Noire</source><volume> 47</volume>,<fpage> 56</fpage>-<lpage>59</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.115777-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Benhamiche-Bouvier, A.M., Clinard, F., Dancourt, V. and et Faivre, J. (2001) &amp;#233pid&amp;#233miologie des cancers du tube digestif. Encycl Med Chir (Editions Scientifiques et M&amp;#233dicales Elsevier Sas, Paris, tous droits r&amp;#233serv&amp;#233s), Gastro-Ent&amp;#233rologie, 1-7. https://doi.org/10.1016/S1155-1968(09)50903-0</mixed-citation></ref><ref id="scirp.115777-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">National Cancer Institute (2015) Common Cancer Types. http://www.cancer.gov/types/common-cancers</mixed-citation></ref><ref id="scirp.115777-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Fondation Canadienne de la Sant&amp;#233 digestive (2015) Statistiques sur les cancers. http://www.cdhf.ca/fr/statistiques</mixed-citation></ref></ref-list></back></article>